UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) has been assigned a consensus rating of “Buy” from the twenty-two ratings firms that are presently covering the firm, Marketbeat reports.

The current state of health services highlights crucial sectors facing disruptions and developments, from US foreign aid freezes affecting disease control supply chains, to the FDA's actions on new ...

Trump Targets Big Insurance Companies in Major Offensive** In a bold move that has captured national attention, former President Donald Trump is gearing up to launch a significant offensive against ...

UnitedHealth Group’s stock plummets after DOJ investigation report - UnitedHealth Group have had a tumultuous past year, ...

Luigi Mangione, 26, has pleaded not guilty to multiple counts of murder, including murder as an act of terrorism, in the Dec.

This is part three of a 13-part series about companies whose shares have amassed 100,000% returns for investors and the path ...

Current health news highlights supply chain disruptions for HIV and malaria products due to a U.S. aid freeze, approval of a ...

While the law seeks to level the playing field for many federal employees, the sustainability of the Social Security system ...

The Justice Department is probing diagnoses and practices that triggered extra payments to UnitedHealth’s Medicare Advantage ...

UnitedHealth Group shares tumbled Friday on a report that the U.S. Department of Justice has started an investigation into the health care giant’s Medicare billing practices. The Wall Street Journal ...

Luigi Mangione, who is accused of killing UnitedHealthcare CEO Brian Thompson, had his first court appearance since he was ...